Angela Hartley Brodie

Angela Hartley Brodie
Born Angela Hartley
(1934-09-28) 28 September 1934
Manchester, England
Fields Cancer research
Institutions Worcester Foundation for Experimental Biology
Known for Development of first aromatase inhibitors
Spouse Harry Brodie
Children Mark Brodie
John H. Brodie

Angela Hartley Brodie (born 28 September 1934) is a British cancer researcher who pioneered development of steroidal aromatase inhibitors. Born in Manchester in 1934, Brodie went on to study chemical pathology to a doctoral level and was awarded a fellowship sponsored by National Institutes of Health. After some time working on oral contraceptives with the Harry Brodie, whom she married, she switched focus to the effects of the estrogen-producing enzyme, aromatase, on breast cancer.

Brodie managed to get an aromatase inhibitor into a limited clinical trial in London, which had such a profound effect that it led to Novartis-sponsored trials. She was behind the development of formestane, the first aromatase inhibitor used on breast cancer patients, marketed in 1994. Brodie's work has been hailed "as among the most important contributions to cancer cure."

Biography

Brodie was born Angela Hartley on 28 September 1934[1] in Manchester, England. Her father, Herbert Hartley, was an organic chemist working in polyurethanes[2] who inspired her interest in science.[3] Brodie was educated at a Quaker boarding school before studying at University of Sheffield, where she earned a degree in Biochemistry.[3] After leaving university, she took a job in a blood bank before finding a laboratory position as a research assistant in Department of Hormone Research at Manchester's Christie Cancer Hospital[4][5] Whilst there, she concentrated on estrogen-dependent breast cancer for two years before joining the University of Manchester to study for her doctorate.[3]

Brodie's Ph.D. in chemical pathology,[6] which she received in 1961 from University of Manchester,[7] focussed primarily on the hormone aldosterone.[3]

As a result of her doctorate, she was awarded a National Institutes of Health sponsored, 1-year post-doctoral training fellowship, at Clark University and the Worcester Foundation for Experimental Biology in Shrewsbury, Massachusetts.[6][8] She researched at Worcester Foundation between 1962[3] and 1979.[6]

There, she worked initially on the oral contraceptive usage of aldosterone, alongside a number of scientists including Dr. Harry Brodie, who Angela Brodie lmarried, and Dr. Mika Hayano,[3] who died of breast cancer in her 40s. Over the next few years, Brodie took time away from her work when her two children, Mark and John Hartley Brodie were born.[3]

When Brodie returned to work in 1971 she joined her husband's lab as staff scientist, moving her switch focus to breast cancer research, especially its link with estrogen and an enzyme that produces it, aromatase.[3] and focusing on developing 4-OHA,[4] a potent steroidal aromatase inhibitor, and testing it through clinical trials.[3] 4-OHA, named Formestane, was the first aromatase inhibitor used on breast cancer patients[9] and proved to be a significant improvement on tamoxifen, the standard cancer drug used to treat estrogen receptor-positive breast cancer in postmenopausal women.[10] The drug was first marketed in 1994.[5]

In 1979, encouraged by Cornelia Channing, she joined the University of Maryland School of Medicine, firstly as an associate professor[8] and then later as Professor of Pharmacology and Experimental Therapeutics along with an appointment in the Department of Physiology[10] and a researcher role in the University of Maryland Greenebaum Cancer Center.[10] She presented a paper on her aromatase inhibitors at a Rome conference in 1980, which led to collaboration with Charles Coombes, a British oncologist to start clinical trials on the inhibitor–4-hydroxyandrostenedione (4-OHA) in Royal Marsden Hospital.[3] Coombes gave 4-OHA to 11 women in 1982,[5] with 4 seeing a dramatic improvement. The results were encouraging enough that Novartis was willing to fund further clinical trials.[3]

"Brodie’s major scientific awards recognize her development of aromatase inhibitors in the treatment of breast cancer as among the most important contributions to cancer cure."

Rita M. Rooney[11]

Brodie received the prestigious Kettering Prize in 2005, the first woman to receive the award,[8] though she didn't know she had been nominated[3] At the time, she was on the editorial board of multiple professional journals, reviewed grant applications for NIH[8] and was a member of the integration for the U.S. Army Department of Defense Army Breast Cancer Program.[6] In 2006, her son John, died from accidental drowning.[12][13] To date, Brodie has published over 200 papers in peer-reviewed journals.[10]

Awards

References

  1. ↑ Smith, Linell (20 May 2005). "Cancer researcher honored UM's Angela Brodie first woman to receive Kettering Prize (page 2)". Baltimore Sun. Retrieved 23 January 2016.
  2. ↑ Smith, Linell (20 May 2005). "Cancer researcher honored UM's Angela Brodie first woman to receive Kettering Prize (page 1)". Baltimore Sun. Retrieved 23 January 2016.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 "A Class Above: Dr. Angela Brodie Wins the 2005 Kettering Prize". The Medical Alumni Association of the University of Maryland, Inc. 2005. Retrieved 22 January 2016.
  4. 1 2 Santen, R. J.; Brodie, H.; Simpson, E. R.; Siiteri P. K.; Brodie, A. (1 July 2013). "History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target". Endocrine Reviews 30 (4). ISSN 1945-7189. Retrieved 23 January 2016.
  5. 1 2 3 Grohol, John M. (21 February 2009). "Robert A. Weinberg and Angela M. Hartley Brodie awarded 2006 Landon-AACR Prizes for Cancer Research". PsycheCentral. Retrieved 23 January 2016.
  6. 1 2 3 4 5 "Angela M. Hartley Brodie, Ph.D., Is Recipient of 2012 Pharmacia-ASPET Award". University of Maryland Medical Centre. 23 May 2012. Retrieved 22 January 2016.
  7. 1 2 3 "Angela H. Brodie, PhD". Americal Association for Cancer Research. Retrieved 23 January 2016.
  8. 1 2 3 4 5 6 Howard, Barbara (7 October 2010). "Cancer researcher wins 2010 Gabbay Award". Brandeis Now (Brandeis University). Retrieved 22 January 2016.
  9. ↑ Patlak, Margie; Nass, Sharyl J. (12 June 2012). The Role of Obesity in Cancer Survival and Recurrence. National Academies Press. p. 94. ISBN 9780309253369.
  10. 1 2 3 4 5 6 "Angela Hartley Brodie, PhD". University of Maryland Medical Centre. Retrieved 22 January 2016.
  11. ↑ Rooney, Rita M. (2012). "Aromatase Inhibitors" (PDF). Medical Bulletin (University of Maryland) 97 (2): 8–11. Retrieved 24 January 2016.
  12. ↑ "John Hartley Brodie". Find a Grave. Retrieved 23 January 2016.
  13. ↑ "John Brodie: Obituary". Brattleboro Reformer. 16 February 2006. Retrieved 23 January 2016.
  14. ↑ "Awards & Recognition: Previous Brinker Award Recipients: 2000 Recipients". Susan . Komen. Retrieved 24 January 2016.
  15. ↑ "Another milestone reached for national recognized breast program" (PDF). Health News (University of Maryland Medicine). June 2005. Retrieved 22 January 2016.
  16. ↑ Warmkessel, Karen (28 February 2006). "University of Maryland Cancer Researcher to Receive Dorothy P Landon AACR Prize for Translational Cancer Research". University of Maryland Medical Center. Retrieved 22 January 2016.
  17. ↑ "Angela Hartley Brodie, PhD, Wins Health Care Heroes Award". University of Maryland Medical Center. 4 June 2008. Retrieved 22 January 2016.
  18. ↑ "Dr. Angela Brodie Awarded Pincus Medal". University of Maryland Medical Centre. 25 June 2007. Retrieved 22 January 2016.
  19. ↑ "Forty-one ATD for Cancer 6th ed Doctors Named as Breast Cancer Grant Recipients". Castle Connolly Top Doctors. 29 October 2010. Retrieved 23 January 2016.
  20. ↑ "We Are Family". New York Social Diary. 3 November 2010. Retrieved 23 January 2016.
  21. ↑ "Fellows of the AACR Academy". American Association for Cancer Research. Retrieved 23 January 2016.
  22. ↑ "University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy". PR Newswire. 28 March 2013. Retrieved 23 January 2016.

External links

This article is issued from Wikipedia - version of the Thursday, April 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.